Enact Reports Fourth Quarter 2022 Results
Fourth quarter GAAP Net Income of
Full year GAAP Net Income of
Fourth quarter Adjusted Operating Income of
Full year Adjusted Operating Income of
Fourth quarter Return on Equity of 14.0% and Adjusted Operating Return on Equity of 14.4%
PMIERs Sufficiency of 165% or
Returned over
Book Value Per Share of
“The fourth quarter completed a strong year for Enact,” said
Key Financial Highlights
(In millions, except per share data or otherwise noted) | 4Q22 | 3Q22 | 4Q21 | 2022 | 2021 | |||||||||||||
Net Income (loss) | ||||||||||||||||||
Diluted Net Income (loss) per share | ||||||||||||||||||
Adjusted Operating Income (loss) | ||||||||||||||||||
Adj. Diluted Operating Income (loss) per share | ||||||||||||||||||
NIW ($B) | ||||||||||||||||||
Primary IIF ($B) | ||||||||||||||||||
Persistency | 86 | % | 82 | % | 69 | % | 80 | % | 62 | % | ||||||||
Net Premiums Earned | ||||||||||||||||||
Losses Incurred | $(40 | ) | $(94 | ) | ||||||||||||||
Loss Ratio | 8 | % | (17 | )% | 3 | % | (10 | )% | 13 | % | ||||||||
Operating Expenses | ||||||||||||||||||
Expense Ratio | 27 | % | 25 | % | 25 | % | 25 | % | 25 | % | ||||||||
Net Investment Income | ||||||||||||||||||
Return on Equity | 14.0 | % | 18.6 | % | 14.8 | % | 17.2 | % | 13.7 | % | ||||||||
Adjusted Operating Return on Equity | 14.4 | % | 18.6 | % | 14.8 | % | 17.3 | % | 13.8 | % | ||||||||
PMIERs Sufficiency ($) | ||||||||||||||||||
PMIERs Sufficiency (%) | 165 | % | 174 | % | 165 | % |
Fourth Quarter 2022 Financial and Operating Highlights
- Net income was
$144 million , or$0.88 per diluted share, compared with$191 million , or$1.17 per diluted share, for the third quarter of 2022 and$154 million , or$0.94 per diluted share, for the fourth quarter of 2021. The sequential decline in net income was primarily driven by higher losses from the lower net favorable reserve development in the current quarter. The year-over-year decline in net income was primarily driven by higher losses on new delinquencies. - Adjusted operating income was
$147 million , or$0.90 per diluted share, compared with$191 million , or$1.17 per diluted share, for the third quarter of 2022 and$154 million , or$0.94 per diluted share, for the fourth quarter of 2021. - New insurance written (NIW) was
$15 billion , up 1% from$15 billion in the third quarter of 2022 and down 29% from$21 billion in the fourth quarter of 2021. The current quarter included a one-time seasoned deal. Excluding this deal, NIW was down 4% sequentially and down 32% from the prior year due to lower originations as a result of increased mortgage rates. NIW for the current quarter was comprised of 91% monthly premium policies and 97% purchase originations. - Primary Insurance-In-Force was
$248 billion , up 3% from$242 billion in the third quarter of 2022 and up 10% from$227 billion in the fourth quarter of 2021, driven by NIW and increased persistency. - Persistency was 86%, up from 82% in the third quarter of 2022 and 69% in the fourth quarter of 2021. The continued increase in persistency has been driven by an increase in mortgage rates and a low percentage of our portfolio with rates 50 basis points above current market rates.
- Net premiums earned were
$233 million , down 1% from$235 million in the third quarter of 2022 and down 2% from$237 million in the fourth quarter of 2021. Net earned premium yield was down from the third quarter of 2022 and the fourth quarter of 2021, driven by the lapse of older, higher-priced policies as compared to our new insurance written and lower single premium cancellations along with modestly higher ceded premiums as compared to fourth quarter of 2021. The decline in net earned premium yield was partially offset by IIF growth. - Losses incurred for the fourth quarter of 2022 were
$18 million and the loss ratio was 8%, compared to$(40) million and (17)%, respectively, in the third quarter of 2022, driven by a reserve release of$63 million on favorable cure performance from 2021 and prior delinquencies (primarily COVID related), partially offset by$21 million reserve strengthening related to 2022 delinquencies and incurred but not reported reserves given heightened economic uncertainty. The net reserve release of$42 million compares to a net reserve release of$80 million in the third quarter of 2022. Current quarter losses incurred and the loss ratio compare unfavorably to results for the fourth quarter 2021 of$6 million and 3%, respectively, driven by higher losses. The higher losses were from a higher estimated claim rate on new delinquencies in the current quarter and increased new delinquencies from recent large books that are aging and going through their normal loss development pattern partially offset by a larger favorable net reserve development in the current quarter. - The percentage of loans in default at quarter end was 2.08%, or 2.01% excluding new delinquencies from natural disasters in
FEMA -impacted areas in the current quarter. This compared to 1.99% as ofSeptember 30, 2022 and 2.65% as ofDecember 31, 2021 which was elevated due to COVID-related delinquencies. - Operating expenses in the current quarter were
$63 million and the expense ratio was 27%, which were impacted by$3 million and one percentage point, respectively, due to one-time restructuring costs driven by a voluntary separation program executed in the fourth quarter. This compared to$58 million and 25%, respectively, in the third quarter of 2022 and$59 million and 25%, respectively in the fourth quarter of 2021. The increase in expenses and expense ratio was primarily driven by the restructuring costs and higher general and administrative costs, partially offset by lower variable costs associated with production volume as compared to the fourth quarter of 2021. - Net investment income was
$45 million , up from$39 million for the third quarter of 2022 and$35 million in the fourth quarter of 2021, driven by rising interest rates and higher average invested assets and partially offset by lower bond calls. - Annualized return on equity for the fourth quarter of 2022 was 14.0% and annualized adjusted operating return on equity was 14.4%. This compares to third quarter 2022 results of 18.6% and 18.6%, respectively, and to fourth quarter 2021 results of 14.8% and 14.8%, respectively. The sequential decrease in both return on equity and adjusted operating return on equity were driven, in part, by a larger net reserve release in the third quarter of 2022 as compared to the current quarter, partially offset by the payment of our quarterly dividend of
$23 million , or$0.14 per share, and the payment of our special cash dividend of$183 million , or$1.12 per share, in the fourth quarter of 2022.
Capital and Liquidity
- PMIERs sufficiency was 165% and
$2,050 million above the published PMIERs requirements, compared to 174% and$2,249 million above the published PMIERs requirements in the third quarter of 2022. The sequential decrease in PMIERs sufficiency was primarily driven by the$242 million distribution from our flagship insurance writer and NIW, partially offset by our business cash flows and lapse. - PMIERs sufficiency benefited from a 0.30 multiplier applied to the risk-based required asset factor for certain non-performing loans, which resulted in a reduction of the published PMIERs required assets by an estimated
$132 million at the end of the current quarter, compared to$140 million at the end of the third quarter 2022 and$390 million at the end of the fourth quarter 2021. These amounts are gross of incremental reinsurance benefits from the elimination of the 0.30 multiplier. Enact Holdings, Inc. held$206 million of cash and$247 million of invested assets as ofDecember 31, 2022 . Combined cash and invested assets increased$40 million from the prior quarter, due to the$242 million distribution from our flagship insurance writer, partially offset by our combined dividends of$206 million .
Recent Events
- In November, Enact announced that its Board of Directors had authorized a
$75 million share repurchase program. ThroughJanuary 31, 2023 , repurchases under the program have totaled$8 million . - As of year-end, Enact and Genworth believe that the required financial conditions and rating requirements have been satisfied. Upon GSE confirmation, we expect the GSE restrictions first imposed upon Enact after issuance of the
August 2020 senior notes will be lifted and we will no longer be subject to more stringent capital requirements than our peers.
Conference Call and Financial Supplement Information
This press release, the fourth quarter 2022 financial supplement and earnings presentation are now posted on the Company’s website, https://ir.enactmi.com. Investors are encouraged to review these materials.
Enact will discuss fourth quarter financial results in a conference call tomorrow,
The webcast also will be archived on the company’s website for one year.
About Enact
Enact (Nasdaq: ACT), operating principally through its wholly-owned subsidiary
Safe Harbor Statement
This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act. These forward-looking statements may address, among other things, our expected financial and operational results, the related assumptions underlying our expected results, and the quotations of management. These forward-looking statements are distinguished by use of words such as “will,” “may,” “would,” “anticipate,” “expect,” “believe,” “designed,” “plan,” “predict,” “project,” “target,” “could,” “should,” or “intend,” the negative of these terms, and similar references to future periods. These views involve risks and uncertainties that are difficult to predict and, accordingly, our actual results may differ materially from the results discussed in our forward-looking statements. Our forward-looking statements contained herein speak only as of the date of this press release. Factors or events that we cannot predict, including uncertainty around Covid-19 and the effects of government and other measures seeking to contain its spread; supply chain constraints; inflation; increases in interest rates; risks related to an economic downturn or recession in
GAAP/Non-GAAP Disclosure Discussion
This communication includes the non-GAAP financial measures entitled “adjusted operating income (loss)”, “adjusted operating income (loss) per share," and “adjusted operating return on equity." Adjusted operating income (loss) per share is derived from adjusted operating income (loss). The chief operating decision maker evaluates performance and allocates resources on the basis of adjusted operating income (loss). The
While some of these items may be significant components of net income (loss) in accordance with
Adjustments to reconcile net income (loss) available to the Company’s common stockholders to adjusted operating income (loss) assume a 21% tax rate.
The tables at the end of this press release provide a reconciliation of net income (loss) to adjusted operating income (loss) and
Exhibit A: Consolidated Statements of Income (amounts in thousands, except per share amounts)
4Q22 | 3Q22 | 4Q21 | 2022 | 2021 | |||||||||||
REVENUES: | |||||||||||||||
Premiums | |||||||||||||||
Net investment income | 44,896 | 39,493 | 35,246 | 155,311 | 141,189 | ||||||||||
Net investment gains (losses) | (1,274 | ) | (42 | ) | 5 | (2,036 | ) | (2,124 | ) | ||||||
Other income | 483 | 564 | 727 | 2,309 | 3,841 | ||||||||||
Total revenues | 276,842 | 275,075 | 272,842 | 1,095,046 | 1,117,855 | ||||||||||
LOSSES AND EXPENSES: | |||||||||||||||
Losses incurred | 18,097 | (40,309 | ) | 5,972 | (94,221 | ) | 125,473 | ||||||||
Acquisition and operating expenses, net of deferrals | 59,955 | 54,523 | 55,630 | 226,941 | 231,453 | ||||||||||
Amortization of deferred acquisition costs and intangibles | 2,747 | 3,338 | 3,600 | 12,405 | 14,704 | ||||||||||
Interest expense | 13,258 | 12,879 | 12,771 | 51,699 | 51,009 | ||||||||||
Total losses and expenses | 94,057 | 30,431 | 77,973 | 196,824 | 422,639 | ||||||||||
INCOME BEFORE INCOME TAXES | 182,785 | 244,644 | 194,869 | 898,222 | 695,216 | ||||||||||
Provision for income taxes | 38,979 | 53,658 | 41,335 | 194,065 | 148,531 | ||||||||||
NET INCOME | $143,806 | $190,986 | $153,534 | $704,157 | $546,685 | ||||||||||
Net investment (gains) losses | 1,274 | 42 | (5 | ) | 2,036 | 2,124 | |||||||||
Costs associated with reorganization | 3,291 | (156 | ) | 89 | 3,461 | 2,744 | |||||||||
Taxes on adjustments | (959 | ) | 24 | (17 | ) | (1,155 | ) | (1,022 | ) | ||||||
Adjusted Operating Income | $147,412 | $190,896 | $153,601 | $708,499 | $550,531 | ||||||||||
Loss ratio (1) | 8 | % | (17 | )% | 3 | % | (10 | )% | 13 | % | |||||
Expense ratio (2) | 27 | % | 25 | % | 25 | % | 25 | % | 25 | % | |||||
Earnings Per Share Data: | |||||||||||||||
Net Income per share | |||||||||||||||
Basic | |||||||||||||||
Diluted | |||||||||||||||
Adj operating income per share | |||||||||||||||
Basic | |||||||||||||||
Diluted | |||||||||||||||
Weighted-average common shares outstanding | |||||||||||||||
Basic | 162,824 | 162,843 | 162,840 | 162,838 | 162,840 | ||||||||||
Diluted | 163,520 | 163,376 | 162,985 | 163,294 | 162,879 |
(1) The ratio of losses incurred to net earned premiums.
(2) The ratio of acquisition and operating expenses, net of deferrals, and amortization of deferred acquisition costs and intangibles to net earned premiums. Expenses associated with strategic transaction preparations and restructuring costs decreased the expense ratio by one percentage point for the three months ended
Exhibit B: Consolidated Balance Sheets (amounts in thousands, except per share amounts)
Assets | 4Q22 | 3Q22 | 4Q21 | ||||||
Investments: | |||||||||
Fixed maturity securities available-for-sale, at fair value | |||||||||
Short term investments | 3,047 | 2,434 | — | ||||||
Total investments | 4,887,807 | 4,880,336 | 5,266,339 | ||||||
Cash and cash equivalents | 513,775 | 535,775 | 425,828 | ||||||
Accrued investment income | 35,844 | 35,896 | 31,061 | ||||||
Deferred acquisition costs | 26,121 | 26,310 | 27,220 | ||||||
Premiums receivable | 41,738 | 40,331 | 42,266 | ||||||
Deferred tax asset | 127,473 | 135,152 | — | ||||||
Other assets | 76,391 | 69,040 | 73,059 | ||||||
Total assets | $5,709,149 | $5,722,840 | $5,865,773 | ||||||
Liabilities and Shareholders' Equity | |||||||||
Liabilities: | |||||||||
Loss reserves | |||||||||
Unearned premiums | 202,717 | 212,987 | 246,319 | ||||||
Other liabilities | 143,686 | 140,413 | 130,604 | ||||||
Long-term borrowings | 742,830 | 742,211 | 740,416 | ||||||
Deferred tax liability | — | — | 1,586 | ||||||
Total liabilities | 1,608,241 | 1,605,848 | 1,760,250 | ||||||
Equity: | |||||||||
Common stock | 1,628 | 1,628 | 1,628 | ||||||
Additional paid-in capital | 2,382,068 | 2,379,576 | 2,371,861 | ||||||
Accumulated other comprehensive income | (382,744 | ) | (427,085 | ) | 83,581 | ||||
Retained earnings | 2,099,956 | 2,162,873 | 1,648,453 | ||||||
Total equity | 4,100,908 | 4,116,992 | 4,105,523 | ||||||
Total liabilities and equity | $5,709,149 | $5,722,840 | $5,865,773 | ||||||
Book value per share | |||||||||
Book value per share excluding AOCI | |||||||||
14.0 | % | 18.6 | % | 14.8 | % | ||||
Net investment (gains) losses | 0.1 | % | 0.0 | % | 0.0 | % | |||
Costs associated with reorganization | 0.3 | % | 0.0 | % | 0.0 | % | |||
Taxes on adjustments | (0.1 | )% | 0.0 | % | 0.0 | % | |||
Adjusted Operating ROE(2) | 14.4 | % | 18.6 | % | 14.8 | % | |||
Debt to Capital Ratio | 15 | % | 15 | % | 15 | % |
(1) Calculated as annualized net income for the period indicated divided by the average of current period and prior periods’ ending total stockholders’ equity
(2) Calculated as annualized adjusted operating income for the period indicated divided by the average of current period and prior periods’ ending total stockholders’ equity
Investor ContactDaniel Kohl [email protected] Media ContactSarah Wentz [email protected]
Source:
540.6 KB
Reports from Landmark University Add New Data to Research in Public Health (Perception among NHIS-HMO Enrolees of the Attitudes of Medical Personnel during Outpatient Care in Lagos Hospitals): Health and Medicine – Public Health
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News